- Home
- ENVB vs WLDS Comparison
ENVB vs WLDS Comparison
Compare ENVB & WLDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENVB
- WLDS
- Stock Information
- Founded
- ENVB 1994
- WLDS 2014
- Country
- ENVB United States
- WLDS Israel
- Employees
- ENVB N/A
- WLDS 37
- Industry
- ENVB Biotechnology: Pharmaceutical Preparations
- WLDS Computer Communications Equipment
- Sector
- ENVB Health Care
- WLDS Telecommunications
- Exchange
- ENVB Nasdaq
- WLDS Nasdaq
- Market Cap
- ENVB 4.1M
- WLDS 4.0M
- IPO Year
- ENVB N/A
- WLDS 2022
- Fundamental
- Price
- ENVB $0.35
- WLDS $1.43
- Analyst Decision
- ENVB Strong Buy
- WLDS
- Analyst Count
- ENVB 1
- WLDS 0
- Target Price
- ENVB $10.00
- WLDS N/A
- AVG Volume (30 Days)
- ENVB 1.0M
- WLDS 510.3K
- Earning Date
- ENVB 11-14-2024
- WLDS 12-24-2024
- Dividend Yield
- ENVB N/A
- WLDS N/A
- EPS Growth
- ENVB N/A
- WLDS N/A
- EPS
- ENVB N/A
- WLDS N/A
- Revenue
- ENVB N/A
- WLDS $464,000.00
- Revenue This Year
- ENVB N/A
- WLDS N/A
- Revenue Next Year
- ENVB N/A
- WLDS N/A
- P/E Ratio
- ENVB N/A
- WLDS N/A
- Revenue Growth
- ENVB N/A
- WLDS 1500.00
- 52 Week Low
- ENVB $0.30
- WLDS $1.20
- 52 Week High
- ENVB $2.92
- WLDS $16.00
- Technical
- Relative Strength Index (RSI)
- ENVB 46.61
- WLDS 38.68
- Support Level
- ENVB $0.35
- WLDS $1.35
- Resistance Level
- ENVB $0.39
- WLDS $1.60
- Average True Range (ATR)
- ENVB 0.05
- WLDS 0.28
- MACD
- ENVB -0.00
- WLDS -0.04
- Stochastic Oscillator
- ENVB 19.56
- WLDS 16.20
About ENVB Enveric Biosciences Inc.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders. The company's lead program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. Enveric is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, being studied as a treatment of psychiatric disorders.
About WLDS Wearable Devices Ltd.
Wearable Devices Ltd develops a non-invasive Neural input interface for controlling digital devices using subtle finger movements. These digital devices include consumer electronics, smart watches, smartphones, AR glasses, VR headsets, televisions, PCs, laptop computers, drones, robots, etc. The company has completed the transition phase from research and development to commercialization of technology into B2B and B2C products. Its products include Mudra Inspire, a band for the Apple Watch that allows touchless operation and control of Apple ecosystem devices such as iPhone, Mac computer, Apple TV, and iPad, inter alia.